Vízkeleti L - Search Results

1

[EGFR protein is a negative prognostic and predictive factor in wild-type RAS colorectal cancer].

Uhlyarik A, Piurkó V, Pápai Z, Rásó E, Lahm E, Kiss E, Sikter M, Vachaja J, Vízkeleti L, Kenessey I, Tímár J. Uhlyarik A, et al. Among authors: vizkeleti l. Magy Onkol. 2021 Jun 3;65(2):121-127. Epub 2021 May 16. Magy Onkol. 2021. PMID: 34081760 Free article. Hungarian.

2

[Biological role and prognostic significance of genetic alterations in human malignant melanomas].

Vízkeleti L. Vízkeleti L. Magy Onkol. 2015 Sep;59(3):268-72. Epub 2015 Feb 20. Magy Onkol. 2015. PMID: 26339916 Free article. Hungarian.

3

[Melanoma research in Hungary: promising results in a previously orphan tumor].

Balázs M, Vízkeleti L, Ecsedi S, Ádány R, Rásó E, Hegedûs B, Ladányi A, Tóvári J, Tímár J. Balázs M, et al. Among authors: vizkeleti l. Magy Onkol. 2015 Dec;59(4):275-81. Epub 2015 Oct 25. Magy Onkol. 2015. PMID: 26665186 Free article. Hungarian.

4

Genetic progression of malignant melanoma.

Tímár J, Vizkeleti L, Doma V, Barbai T, Rásó E. Tímár J, et al. Among authors: vizkeleti l. Cancer Metastasis Rev. 2016 Mar;35(1):93-107. doi: 10.1007/s10555-016-9613-5. Cancer Metastasis Rev. 2016. PMID: 26970965 Review.

5

EGFR Protein Expression of KRAS Wild-Type Colorectal Cancer: Predictive Value of the Sidedness for Efficacy of Anti-EGFR Therapy.

Uhlyarik A, Piurko V, Vizkeleti L, Pápai Z, Rásó E, Lahm E, Kiss E, Sikter M, Vachaja J, Kenessey I, Tímár J. Uhlyarik A, et al. Among authors: vizkeleti l. Pathol Oncol Res. 2020 Jul;26(3):1429-1434. doi: 10.1007/s12253-018-00572-2. Epub 2019 Jan 5. Pathol Oncol Res. 2020. PMID: 30612313 Free article.

6

[Molecular background of BRAF inhibitor induced resistance in BRAFV600E mutant melanoma cell lines].

Szász I, Koroknai V, Vízkeleti L, Balázs M. Szász I, et al. Among authors: vizkeleti l. Magy Onkol. 2021 Jun 3;65(2):149-156. Epub 2021 May 18. Magy Onkol. 2021. PMID: 34081762 Free article. Hungarian.

7

Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma.

Papp O, Doma V, Gil J, Markó-Varga G, Kárpáti S, Tímár J, Vízkeleti L. Papp O, et al. Among authors: vizkeleti l. Cancers (Basel). 2021 Nov 28;13(23):5984. doi: 10.3390/cancers13235984. Cancers (Basel). 2021. PMID: 34885093 Free PMC article.

8

Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy.

Ladányi A, Rásó E, Barbai T, Vízkeleti L, Puskás LG, Kovács SA, Győrffy B, Tímár J. Ladányi A, et al. Among authors: vizkeleti l. Int J Mol Sci. 2022 Feb 28;23(5):2704. doi: 10.3390/ijms23052704. Int J Mol Sci. 2022. PMID: 35269844 Free PMC article.

9

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries.

Pipek O, Vizkeleti L, Doma V, Alpár D, Bödör C, Kárpáti S, Timar J. Pipek O, et al. Among authors: vizkeleti l. Cancers (Basel). 2023 Mar 10;15(6):1712. doi: 10.3390/cancers15061712. Cancers (Basel). 2023. PMID: 36980598 Free PMC article.

10

Identification of genetic fingerprint of type I interferon therapy in visceral metastases of melanoma.

Vízkeleti L, Papp O, Doma V, Gil J, Markó-Varga G, Kovács SA, Győrffy B, Kárpáti S, Tímár J. Vízkeleti L, et al. Sci Rep. 2024 Nov 3;14(1):26540. doi: 10.1038/s41598-024-77285-x. Sci Rep. 2024. PMID: 39489756 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters